Phenylpyridazine compounds and medicines containing the same
申请人:Kowa Co., Ltd.
公开号:US06664256B1
公开(公告)日:2003-12-16
Phenylpyridazine compounds represented by the following formula (I):
are provided, wherein R1, R2, R3, R4, and n are as defined herein having excellent inhibitory activity against interleukin-1&bgr; production, and useful in the treatment of prevention of diseases caused by stimulation of interleukin-1&bgr; production, such as immune system diseases, inflammatory diseases, and ischemic diseases.
PHENYLPYRIDAZINE DERIVATIVES AND DRUGS CONTAINING THE SAME
申请人:Kowa Co., Ltd.
公开号:EP1300399B1
公开(公告)日:2007-08-22
Mono- and Di-substituted 5,6-Diphenyl-3-alkylaminopyridazines Active as ACAT Inhibitors
作者:Lucio Toma、Maria Paola Giovannoni、Vittorio Dal Piaz、Byoung-Mog Kwon、Young-Kook Kim、Arianna Gelain、Daniela Barlocco
DOI:10.3987/com-01-9351
日期:——
A series of mono- or di-para-substituted 5,6-diphenyl-3-alkylaminopyridazines were synthesized and their inhibitory activity against acylCoA:cholesterol acyltransferase (ACAT) was tested on the enzyme prepared from rat liver microsomes. The compound which combines a chlorine atom on the 6-phenyl ring and a n-hexylamino chain showed a significant enhancement of activity with respect to the unsubstituted derivative. Attempts to correlate the activity of the compounds to their structural features, also through theoretical calculations, are reported.